Literature DB >> 16970695

Treatment of angiokeratoma of Fordyce with pulsed dye laser.

Moshe Lapidoth1, Dean Ad-El, Michael David, Ron Azaria.   

Abstract

BACKGROUND: Angiokeratomas of Fordyce are typically asymptomatic vascular lesions characterized by blue-to-red papules with a scale surface, most often located on the scrotum. Although considered benign, the lesions may bleed, either spontaneously or secondary to rupture, leading to patient anxiety and social embarrassment.
OBJECTIVE: The objective was to determine the safety and effectiveness of 585-nm pulsed dye laser for the treatment of angiokeratomas of Fordyce.
METHODS: Twelve patients with Fitzpatrick skin type II to IV were treated for angiokeratomas of Fordyce with pulsed dye laser (5.5-8.0 J/cm(2)) in two to six sessions. Lesion clearance was evaluated by two specialists on the basis of digital photographs taken before the first treatment and 2 months after the last treatment.
RESULTS: Seven patients had an excellent response (clearance rating 75%-100%) and five patients had a good response (clearance rating 50%-75%). Transient purpura and pain were present in all patients. Bleeding during treatment occurred in five patients. There were no permanent side effects.
CONCLUSION: Pulsed dye laser is effective and safe for the treatment of angiokeratoma of Fordyce, with minimum side effects, providing an additional nonablative therapeutic option.

Entities:  

Mesh:

Year:  2006        PMID: 16970695     DOI: 10.1111/j.1524-4725.2006.32252.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  2 in total

1.  Solitary angiokeratoma of the tongue treated with diode laser.

Authors:  Sertan Ergun; Ozgür Mete; Semen Yeşil; Hakký Tanyeri
Journal:  Lasers Med Sci       Date:  2007-12-05       Impact factor: 3.161

Review 2.  Penile Angiokeratomas (PEAKERs) Revisited: A Comprehensive Review.

Authors:  Philip R Cohen; Nicholas J Celano
Journal:  Dermatol Ther (Heidelb)       Date:  2020-06-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.